Tags

Type your tag names separated by a space and hit enter

Myocardial infarction increases ACE2 expression in rat and humans.
Eur Heart J. 2005 Feb; 26(4):369-75; discussion 322-4.EH

Abstract

AIMS

Angiotensin converting enzyme (ACE) 2 catalyses the cleavage of angiotensin (Ang) I to Ang 1-9 and of Ang II to Ang 1-7. ACE2 deficiency impairs cardiac contractility and upregulates hypoxia-induced genes, suggesting a link with myocardial ischaemia. We studied the expression of ACE2 after myocardial infarction (MI) in the rat as well as in human failing hearts.

METHODS AND RESULTS

Rats were killed at days 1, 3, and 28 after MI, or treated for 4 weeks with the ACE inhibitor ramipril (1 mg/kg). Cardiac gene and protein expression of ACE and ACE2 were assessed by quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry/activity assays/in vitro autoradiography, respectively. Both ACE (P = 0.022) and ACE2 (P = 0.015) mRNA increased in the border/infarct area compared with the viable area at day 3 after MI. By day 28, increases in ACE (P = 0.005) and ACE2 (P = 0.006) mRNA were also seen in the viable myocardium of MI rats compared with myocardium of control rats. ACE2 protein localized to macrophages, vascular endothelium, smooth muscle, and myocytes. Ramipril attenuated cardiac hypertrophy and inhibited cardiac ACE. In contrast, ramipril had no effect on cardiac ACE2 mRNA, which remained elevated in all areas of the MI rat heart. Immunoreactivity of both ACE and ACE2 increased in failing human hearts.

CONCLUSION

The increase in ACE2 after MI suggests that it plays an important role in the negative modulation of the renin angiotensin system in the generation and degradation of angiotensin peptides after cardiac injury.

Authors+Show Affiliations

Department of Medicine, University of Melbourne, Austin Health, Repatriation Heidelberg Hospital, Heidelberg 3081, Victoria, Australia. l.burrell@unimelb.edu.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15671045

Citation

Burrell, Louise M., et al. "Myocardial Infarction Increases ACE2 Expression in Rat and Humans." European Heart Journal, vol. 26, no. 4, 2005, pp. 369-75; discussion 322-4.
Burrell LM, Risvanis J, Kubota E, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26(4):369-75; discussion 322-4.
Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., Cooper, M. E., & Johnston, C. I. (2005). Myocardial infarction increases ACE2 expression in rat and humans. European Heart Journal, 26(4), 369-75; discussion 322-4.
Burrell LM, et al. Myocardial Infarction Increases ACE2 Expression in Rat and Humans. Eur Heart J. 2005;26(4):369-75; discussion 322-4. PubMed PMID: 15671045.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Myocardial infarction increases ACE2 expression in rat and humans. AU - Burrell,Louise M, AU - Risvanis,John, AU - Kubota,Eiji, AU - Dean,Rachael G, AU - MacDonald,Peter S, AU - Lu,Sai, AU - Tikellis,Christos, AU - Grant,Sharon L, AU - Lew,Rebecca A, AU - Smith,A Ian, AU - Cooper,Mark E, AU - Johnston,Colin I, Y1 - 2005/01/25/ PY - 2005/1/27/pubmed PY - 2005/6/7/medline PY - 2005/1/27/entrez SP - 369-75; discussion 322-4 JF - European heart journal JO - Eur Heart J VL - 26 IS - 4 N2 - AIMS: Angiotensin converting enzyme (ACE) 2 catalyses the cleavage of angiotensin (Ang) I to Ang 1-9 and of Ang II to Ang 1-7. ACE2 deficiency impairs cardiac contractility and upregulates hypoxia-induced genes, suggesting a link with myocardial ischaemia. We studied the expression of ACE2 after myocardial infarction (MI) in the rat as well as in human failing hearts. METHODS AND RESULTS: Rats were killed at days 1, 3, and 28 after MI, or treated for 4 weeks with the ACE inhibitor ramipril (1 mg/kg). Cardiac gene and protein expression of ACE and ACE2 were assessed by quantitative real-time reverse transcriptase-polymerase chain reaction and immunohistochemistry/activity assays/in vitro autoradiography, respectively. Both ACE (P = 0.022) and ACE2 (P = 0.015) mRNA increased in the border/infarct area compared with the viable area at day 3 after MI. By day 28, increases in ACE (P = 0.005) and ACE2 (P = 0.006) mRNA were also seen in the viable myocardium of MI rats compared with myocardium of control rats. ACE2 protein localized to macrophages, vascular endothelium, smooth muscle, and myocytes. Ramipril attenuated cardiac hypertrophy and inhibited cardiac ACE. In contrast, ramipril had no effect on cardiac ACE2 mRNA, which remained elevated in all areas of the MI rat heart. Immunoreactivity of both ACE and ACE2 increased in failing human hearts. CONCLUSION: The increase in ACE2 after MI suggests that it plays an important role in the negative modulation of the renin angiotensin system in the generation and degradation of angiotensin peptides after cardiac injury. SN - 0195-668X UR - https://www.unboundmedicine.com/medline/citation/15671045/Myocardial_infarction_increases_ACE2_expression_in_rat_and_humans_ L2 - https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehi114 DB - PRIME DP - Unbound Medicine ER -